{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T06:13:05Z","timestamp":1782627185662,"version":"3.54.5"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the associations between several laboratory parameters and plasma neurofilament light chain (pNfL) in individuals with multiple sclerosis (MS), as well as their additional contribution to the established relationships between pNfL, demographics, and MS disability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this cross-sectional study, we included 638 people with MS (PwMS) and evaluated pNfL (using fully automated chemiluminescent enzyme immunoassay), along with demographic, clinical and laboratory variables. Laboratory variables were preliminary selected using univariate linear regression models and multicollinearity analysis. A multivariate linear regression model was then employed to determine independent predictors of pNfL levels. Finally, we used linear regression models to explore the clinical utility of adjusting pNfL level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>On the multivariate linear regression model, higher pNfL was associated with older age (Coeff\u202f=\u202f0.15; 95%CI\u202f=\u202f0.04, 0.26; <jats:italic>p<\/jats:italic>\u202f=\u202f0.007), presence of cardiovascular comorbidity (Coeff\u202f=\u202f3.67; 95%CI\u202f=\u202f0.82, 6.51; <jats:italic>p<\/jats:italic>\u202f=\u202f0.012), higher alkaline phosphatase (ALP) (Coeff\u202f=\u202f0.05; 95%CI\u202f=\u202f0.01, 0.09; <jats:italic>p<\/jats:italic>\u202f=\u202f0.19), higher lymphocytes\u2019 fraction (Coeff\u202f=\u202f0.20; 95%CI\u202f=\u202f0.08,0.33; <jats:italic>p<\/jats:italic>\u202f=\u202f0.001), lower blood proteins (Coeff\u202f=\u202f\u22124.02; 95%CI\u202f=\u202f-6.09, \u22121.96; <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001), and lower hemoglobin (HB) (Coeff\u202f=\u202f\u22121.01; 95%CI\u202f=\u202f\u22121.73, \u22120.27; <jats:italic>p<\/jats:italic>\u202f=\u202f0.007). We confirmed known association between higher pNfL and worse MS-related disability (Coeff\u202f=\u202f2.23; 95%CI\u202f=\u202f1.58, 2.87; &amp;lt;0.001), which did not significantly change after including selected laboratory variables (Coeff\u202f=\u202f1.48; 95%CI\u202f=\u202f0.72, 2.24; <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although laboratory markers of lymphocyte depletion and metabolic\/nutritional status are correlated with pNfL levels, they do not modify its relationship with MS disability.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1620468","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:20:32Z","timestamp":1758082832000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating the contribution of laboratory parameters on plasma neurofilament light chain levels in multiple sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Valerio","family":"Nicolella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gelzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Affinito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sveva","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Addesso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Cernera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"La Civita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Novarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Brescia Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2013 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/s41380-024-02524-6","article-title":"Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls","volume":"29","author":"Bavato","year":"2024","journal-title":"Mol Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e16070","DOI":"10.1111\/ene.16070","article-title":"Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?","volume":"31","author":"Romano","year":"2024","journal-title":"Eur J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jad.2024.09.063","article-title":"Association between serum neurofilament light chains and depression: a cross-sectional study based on NHANES 2013-2014 database","volume":"368","author":"Zhang","year":"2025","journal-title":"J Affect Disord"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"754969","DOI":"10.3389\/fpsyt.2021.754969","article-title":"Neurofilament light chain is a promising biomarker in alcohol dependence","volume":"12","author":"Li","year":"2021","journal-title":"Front Psych"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","article-title":"Epidemiology of multiple sclerosis: global, regional, national and sub-National-Level Estimates and future projections","volume":"15","author":"Khan","year":"2025","journal-title":"J Epidemiol Glob Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"E1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","volume":"80","author":"Abdelhak","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00415-025-13223-9","article-title":"Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis","volume":"272","author":"Nicolella","year":"2025","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/braincomms\/fcaa166","article-title":"Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates","volume":"2","author":"Polymeris","year":"2020","journal-title":"Brain Commun"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1161\/STROKEAHA.119.024941","article-title":"Serum NfL (Neurofilament light chain) levels and incident stroke in adults with diabetes mellitus","volume":"50","author":"Korley","year":"2019","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1212\/WNL.0000000000207419","article-title":"Association of Chronic Kidney Disease with Plasma NfL and other biomarkers of neurodegeneration","volume":"101","author":"Dittrich","year":"2023","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10072-024-07772-6","article-title":"Renal function\u2019s impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis","volume":"46","author":"Tortosa-Carreres","year":"2024","journal-title":"Neurol Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"8556","DOI":"10.1002\/alz.14293","article-title":"Peripheral risk factors and their role in biomarker-based screening for dementia in the community","volume":"20","author":"Hu","year":"2024","journal-title":"Alzheimers Dement"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"574133","DOI":"10.3389\/fmolb.2020.574133","article-title":"Metabolomic biomarkers of multiple sclerosis: a systematic review","volume":"7","author":"Porter","year":"2020","journal-title":"Front Mol Biosci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00415-015-7666-y","article-title":"Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study","volume":"262","author":"Moccia","year":"2015","journal-title":"J Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41398-019-0518-2","article-title":"Plasma neurofilament light chain concentration is increased in anorexia nervosa","volume":"9","author":"Nilsson","year":"2019","journal-title":"Transl Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fendo.2022.915449","article-title":"Association of Plasma Neurofilament Light Chain with Glycaemic Control and Insulin Resistance in middle-aged adults","volume":"13","author":"Thota","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1608211","DOI":"10.3389\/fnut.2025.1608211","article-title":"Association between polyunsaturated fatty acids intake and serum neurofilament light chain concentrations in American adults: a cross-sectional study","volume":"12","author":"Wang","year":"2025","journal-title":"Front Nutr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/acn3.52054","article-title":"Non-neurological factors associated with serum neurofilament levels in the United States population","volume":"11","author":"Ramanathan","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/gerona\/glad058","article-title":"Elevated serum Neurofilament light chain levels are associated with all-cause mortality: evidence from National Health and nutrition examination survey","volume":"78","author":"Chen","year":"2023","journal-title":"J Gerontol Series A"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"123115","DOI":"10.1016\/j.jns.2024.123115","article-title":"Clinical utility of the Lumipulse\u2122 immunoassay for plasma neurofilament light chain in multiple sclerosis","volume":"463","author":"Nicolella","year":"2024","journal-title":"J Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00223-022-01048-x","article-title":"Alkaline phosphatases: biochemistry, functions, and measurement","volume":"112","author":"Makris","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"G241","DOI":"10.1152\/ajpgi.00373.2020","article-title":"Sarcopenia in chronic liver disease: mechanisms and countermeasures","volume":"320","author":"Allen","year":"2021","journal-title":"Am J Physiol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0025-7125(16)33572-6","article-title":"The plasma proteins in liver disease","volume":"47","author":"Osserman","year":"1963","journal-title":"Med Clin North Am"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1007\/s40520-023-02521-9","article-title":"Neurofilament-light chains (NF-L), a biomarker of neuronal damage, is increased in patients with severe sarcopenia: results of the SarcoPhAge study","volume":"35","author":"Ladang","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jcsm.12979","article-title":"Plasma neurofilament light levels associate with muscle mass and strength in middle-aged and older adults: findings from GenoFit","volume":"13","author":"Pratt","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1212\/NXI.0000000000001102","article-title":"Impact of dietary intervention on serum Neurofilament light chain in multiple sclerosis","volume":"9","author":"Bock","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"103471","DOI":"10.1016\/j.msard.2021.103471","article-title":"Sarcopenia in patients with multiple sclerosis","volume":"58","author":"Yuksel","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"106190","DOI":"10.1016\/j.msard.2024.106190","article-title":"Sarcopenia in older people with multiple sclerosis: a cross-sectional study","volume":"93","author":"Gaemelke","year":"2025","journal-title":"Mult Scler Relat Disord"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000381212","article-title":"Association between Anemia and multiple sclerosis","volume":"73","author":"Koudriavtseva","year":"2015","journal-title":"Eur Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40291-021-00566-y","article-title":"Neurofilament light chain as a biomarker in cerebral small-vessel disease","volume":"26","author":"Peters","year":"2022","journal-title":"Mol Diagn Ther"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2193343","article-title":"Relationship between red blood cell indices (MCV, MCH, and MCHC) and major adverse cardiovascular events in anemic and nonanemic patients with acute coronary syndrome","volume":"2022","author":"Zhang","year":"2022","journal-title":"Dis Markers"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.3390\/jcm10122556","article-title":"Anemia is a risk factor for the development of ischemic stroke and post-stroke mortality","volume":"10","author":"Heo","year":"2021","journal-title":"J Clin Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00415-020-10322-7","article-title":"Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis?","volume":"268","author":"Gelibter","year":"2021","journal-title":"J Neurol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years","volume":"4","author":"Simr\u00e9n","year":"2022","journal-title":"Brain Commun"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/ene.14608","article-title":"The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis","volume":"28","author":"Petruzzo","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ana.10147","article-title":"Age-related disability in multiple sclerosis","volume":"51","author":"Trojano","year":"2002","journal-title":"Ann Neurol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1177\/1352458517690618","article-title":"Age related multiple sclerosis severity score: disability ranked by age","volume":"23","author":"Manouchehrinia","year":"2017","journal-title":"Mult Scler J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1212\/NXI.0000000000200279","article-title":"Neurofilament light chain serum levels mirror age and disability in secondary progressive multiple sclerosis","volume":"11","author":"Husseini","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"105044","DOI":"10.1016\/j.msard.2023.105044","article-title":"Low serum 25-hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis","volume":"79","author":"Spiezia","year":"2023","journal-title":"Mult Scler Relat Disord"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1620468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:20:33Z","timestamp":1758082833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1620468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":45,"alternative-id":["10.3389\/fneur.2025.1620468"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1620468","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"article-number":"1620468"}}